These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2891526)

  • 1. Treatment of cryptorchidism with low doses of buserelin over a 6-months period.
    Hadziselimovic F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S56-8. PubMed ID: 2891526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testes.
    Hadziselimović F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
    J Urol; 1987 Oct; 138(4 Pt 2):1043-5. PubMed ID: 2888905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of unilateral cryptorchid boys risking infertility with LH-RH analogue.
    Hadziselimovic F
    Int Braz J Urol; 2008; 34(3):319-26; discussion 327-8. PubMed ID: 18601762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavior of epididymis, processus vaginalis and testicular descent in cryptorchid boys treated with buserelin.
    Bica DT; Hadziselimovic F
    Eur J Pediatr; 1993; 152 Suppl 2():S38-42. PubMed ID: 8101813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for cryptorchid boys risking sterility and results of long-term buserelin treatment after successful orchiopexy.
    Hadziselimovic F; Herzog B; Höcht B; Hecker E; Miescher E; Buser M
    Eur J Pediatr; 1987; 146 Suppl 2():S59-62. PubMed ID: 2891527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with a luteinizing hormone-releasing hormone analogue after successful orchiopexy markedly improves the chance of fertility later in life.
    Hadziselimović F; Herzog B
    J Urol; 1997 Sep; 158(3 Pt 2):1193-5. PubMed ID: 9258170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between adult dark spermatogonia and secretory capacity of Leydig cells in cryptorchidism.
    Zivkovic D; Bica DT; Hadziselimovic F
    BJU Int; 2007 Nov; 100(5):1147-9; discussion 1149. PubMed ID: 17662083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin may reduce the risk of germ cell loss in boys with cryptorchidism.
    Cortes D; Visfeldt J; Thorup JM
    Horm Res; 2001; 55(1):41-5. PubMed ID: 11423742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study.
    Bica DT; Hadziselimovic F
    J Urol; 1992 Aug; 148(2 Pt 2):617-21. PubMed ID: 1353540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual subset of cryptorchidism: possible end organ failure.
    Hadziselimovic F; Snyder HM; Huff DS
    J Urol; 1999 Sep; 162(3 Pt 2):983-5. PubMed ID: 10458416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and postoperative status of gonadotropins (FSH and LH) and inhibin-B in relation to testicular histopathology at orchiopexy in infant boys with unilateral undescended testes.
    Thorup J; Clasen-Linde E; Thorup SC; Cortes D
    J Pediatr Urol; 2015 Feb; 11(1):25.e1-5. PubMed ID: 25267218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between adult dark spermatogonia and other parameters of fertility potential in cryptorchid testes.
    Thorup J; Kvist K; Clasen-Linde E; Petersen BL; Cortes D
    J Urol; 2013 Oct; 190(4 Suppl):1566-71. PubMed ID: 23357211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal therapy for the subfertility of cryptorchidism.
    Huff DS; Snyder HM; Rusnack SL; Zderic SA; Carr MC; Canning DA
    Horm Res; 2001; 55(1):38-40. PubMed ID: 11423741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undescended testis histology correlation with adult hormone levels and semen analysis.
    Kraft KH; Canning DA; Snyder HM; Kolon TF
    J Urol; 2012 Oct; 188(4 Suppl):1429-35. PubMed ID: 22906677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism.
    Cortes D; Thorup JM; Visfeldt J
    Horm Res; 2001; 55(1):21-7. PubMed ID: 11423738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histopathology of iatrogenic cryptorchid testis: an insight into etiology.
    Fenig DM; Snyder HM; Wu HY; Canning DA; Huff DS
    J Urol; 2001 Apr; 165(4):1258-61. PubMed ID: 11257697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intranasal LHRH therapy on plasma LH, FSH and testosterone, and relation to clinical results in prepubertal boys with cryptorchidism.
    Illig R; Torresani T; Bucher H; Zachmann M; Prader A
    Clin Endocrinol (Oxf); 1980 Jan; 12(1):91-7. PubMed ID: 6103766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic impact of testicular biopsies for intratubular germ cell neoplasia in cryptorchid boys and the subsequent risk of testicular cancer in men with prepubertal surgery for syndromic or non-syndromic cryptorchidism.
    Osterballe L; Clasen-Linde E; Cortes D; Engholm G; Hertzum-Larsen R; Reinhardt S; Thorup J
    J Pediatr Surg; 2017 Apr; 52(4):587-592. PubMed ID: 27614808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of germ cells per tubule in testes, serum inhibin B and FSH in cryptorchid boys.
    Cortes D; Thorup J; Hogdall E; Norgaard-Pedersen B; Petersen BL; Hogdall C
    Pediatr Surg Int; 2007 Feb; 23(2):163-9. PubMed ID: 17171380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Undescended testis treated by intranasal application of luteinizing hormone-releasing hormone (LH-RH)].
    Rasmussen TB; Kristensen ES; Gandrup P; Ingerslev HJ
    Ugeskr Laeger; 1991 Feb; 153(9):640-3. PubMed ID: 1672569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.